Personal information

Ovarian Cancer, Breast Cancer, Metastasis, Cancer Stem Cells, Signalling Pathways
United States

Activities

Employment (2)

Stanford University: Stanford, US

2017-09-01 to present | Postdoctoral Research Fellow (Institute for Stem Cell Biology and Regenerative Medicine)
Employment
Source: Self-asserted source
Jane Antony

Imperial College London: London, GB

2016-08-19 to 2017-07-31 | Research Associate (Department of Surgery and Cancer)
Employment
Source: Self-asserted source
Jane Antony

Education and qualifications (2)

Imperial College London: London, GB

2012-08-01 to 2016-07-31 | Ph.D (Department of Surgery and Cancer)
Education
Source: Self-asserted source
Jane Antony

National University of Singapore: Singapore, SG

2008-08-01 to 2012-05-31 | B.Eng (Biomedical Engineering)
Education
Source: Self-asserted source
Jane Antony

Works (8)

LMO2 is critical for early metastatic events in breast cancer

2021-05-26 | Other
Contributors: Shaheen Sikandar; Jane Antony; Gunsagar S. Gulati; Angera H. Kuo; William Hai Dang Ho; Soumyashree Das; Chloé B. Steen; Thiago Almeida Pereira; Dalong Qian; Philip A. Beachy et al.
Source: check_circle
Crossref

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions

Nature Communications
2019-12 | Journal article
Contributors: James R. Birtley; Mohammad Alomary; Elisa Zanini; Jane Antony; Zachary Maben; Grant C. Weaver; Claudia Von Arx; Manuela Mura; Aline T. Marinho; Haonan Lu et al.
Source: check_circle
Crossref

Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention

Physical Biology
2019-05-07 | Journal article
Contributors: Jane Antony; Jean Paul Thiery; Ruby Yun-Ju Huang
Source: check_circle
Crossref

Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation

Scientific Reports
2018-12 | Journal article
Contributors: Maddalena Adorno; Benedetta Nicolis di Robilant; Shaheen Shabbir Sikandar; Veronica Haro Acosta; Jane Antony; Craig H. Heller; Michael F. Clarke
Source: check_circle
Crossref

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer

EMBO reports
2018-08-15 | Journal article
Contributors: Jane Antony; Elisa Zanini; Zoe Kelly; Tuan Zea Tan; Evdoxia Karali; Mohammad Alomary; Youngrock Jung; Katherine Nixon; Paula Cunnea; Christina Fotopoulou et al.
Source: check_circle
Crossref

AXL-driven EMT state as a targetable conduit in cancer

Cancer Research
2017 | Journal article
EID:

2-s2.0-85023746024

Contributors: Antony, J.; Huang, R.Y.-J.
Source: Self-asserted source
Jane Antony via Scopus - Elsevier

The tumor-suppressor protein OPCML potentiates anti–EGFR- and anti–HER2-targeted therapy in HER2-positive ovarian and breast cancer

Molecular Cancer Therapeutics
2017 | Journal article
EID:

2-s2.0-85030629995

Contributors: Zanini, E.; Louis, L.S.; Antony, J.; Karali, E.; Okon, I.S.; McKie, A.B.; Vaughan, S.; El-Bahrawy, M.; Stebbing, J.; Recchi, C. et al.
Source: Self-asserted source
Jane Antony via Scopus - Elsevier

The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer

Science Signaling
2016 | Journal article
EID:

2-s2.0-84990212767

Contributors: Antony, J.; Tan, T.Z.; Kelly, Z.; Low, J.; Choolani, M.; Recchi, C.; Gabra, H.; Thiery, J.P.; Huang, R.Y.-J.
Source: Self-asserted source
Jane Antony via Scopus - Elsevier

Peer review (20 reviews for 9 publications/grants)

Review activity for Biomolecules. (1)
Review activity for Cells. (2)
Review activity for Immunology letters. (1)
Review activity for International journal of molecular sciences. (5)
Review activity for Journal of clinical medicine. (4)
Review activity for Marine drugs. (1)
Review activity for Materials. (2)
Review activity for Nutrients. (2)
Review activity for Pharmaceutics. (2)